Modifi able lifestyle factors and breast cancer outcomes: Current controversies and research recommendations

Advances in Experimental Medicine and Biology

Volumn 862, Issue , 2015, Pages 177-192

  Goodwin, Pamela J ^a   Ambrosone, Christine B ^b   Hong, Chi Chen ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Biologic mediators; Breast cancer; Diet; Exercise; Obesity; Prognosis; Research priorities; Subtype

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; BODY SIZE; BREAST CANCER; CALORIC INTAKE; CANCER PROGNOSIS; CANCER RESEARCH; CANCER SURVIVAL; CANCER SURVIVOR; DISEASE ASSOCIATION; ENERGY EXPENDITURE; HUMAN; LIFESTYLE MODIFICATION; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TOBACCO USE; WEIGHT REDUCTION; BREAST NEOPLASMS; FEMALE; LIFESTYLE; PHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; RESEARCH; RISK FACTOR; RISK REDUCTION; STANDARDS;

NICOTIANA TABACUM;

BODY SIZE; BREAST NEOPLASMS; FEMALE; GUIDELINES AS TOPIC; HUMANS; LIFE STYLE; PROGNOSIS; RESEARCH; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 84931274177     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-16366-6_12     Document Type: Article

References (48)

1. Abbenhardt C, McTiernan A, Alfano CM et al (2013) Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med 274:163–175
2. Abe R, Kumagai N, Kimura M et al (1976) Biological characteristics of breast cancer in obesity. Tohoku J Exp Med 120:351–359
3. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645
4. Ballard-Barbash R, Friedenreich CM, Courneya KS et al (2012) Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 104:815–840
5. Campbell KL, Foster-Schubert KE, Alfano CM et al (2012) Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol 30:2314–2326
6. Cecchini R, Swain S, Costantino J et al (2013) Body mass index at diagnosis and breast cancer survival prognosis among clinical trial populations: results from NSABP B-30, B-31, B-34, and B-38. Cancer Res 73(Suppl 24):Abstract nr PD2-1
7. Chan DS, Vieira AR, Aune D et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. doi: 10.1093/annonc/mdu042
8. Chlebowski RT, Rose D, Buzzard IM et al (1992) Adjuvant dietary fat intake reduction in post-menopausal breast cancer patient management. The women’s intervention nutrition study (WINS). Breast Cancer Res Treat 20:73–84
9. Crozier JA, Moreno-Aspitia A et al (2013) Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831. Cancer 119:2447–2454
10. Demark-Wahnefried W, Goodwin PJ (2013) To your health: how does the latest research on alcohol and breast cancer inform clinical practice? J Clin Oncol 31:1917–1919
11. Demark-Wahnefried W, Aziz NM, Rowland JH et al (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23:5814–5830
12. Ewertz M, Gray KP, Regan MM et al (2012) Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial. J Clin Oncol 30:3967–3975
13. Fontanella C, von Minckwitz G, Mergler B et al (2013) Body mass index (BMI) and treatment outcome of breast cancer patients receiving neoadjuvant therapy (NACT). Cancer Res 73(Suppl 24):Abstract nr PD2-2
14. Fujita K (2006) Cytochrome P450 and anticancer drugs. Curr Drug Metab 7:23–37
15. George SM, Ballard-Barbash R, Shikany JM et al (2014) Better postdiagnosis diet quality is associated with reduced risk of death among postmenopausal women with invasive breast cancer in the women’s health initiative. Cancer Epidemiol Biomarkers Prev 23:575–583
16. Gilbert CA, Slingerland JM (2013) Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Ann Rev Med 64:45–57
17. Goodwin P, Stambolic V (2015) Impact of the obesity epidemic on cancer. Ann Rev Med 66:281–296
18. Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51
19. Goodwin PJ, Stambolic V, Lemieux J et al (2011) Evaluation of metformin in early breast cancer: a modifi cation of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat 126:215–220
20. Goodwin PJ, Ennis M, Pritchard KI et al (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30:164–171
21. Goodwin PJ, Segal RJ, Vallis M et al (2014) Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. J Clin Oncol 32:2231–2239
22. Imayama I, Ulrich CM, Alfano CM et al (2012) Effects of a caloric restriction weight loss diet and exercise on infl ammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 72:2314–2326
23. Johnson KC, Miller AB, Collishaw NE et al (2011) Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian expert panel on tobacco smoke and breast cancer risk (2009). Tob Control 20:e2
24. Kampman E, Vrieling A, van Duijnhoven FJ et al (2012) Impact of diet, body mass index, and physical activity on cancer survival. Curr Nutr Rep 1:30–36
25. Kramer CK, Zinman B, Retnakaran R (2013) Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 159:758–769
26. Kwan ML, Kushi LH, Weltzien E et al (2010) Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol 28:4410–4416
27. Land SR, Cronin WM, Wickerham DL et al (2011) Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the national surgical adjuvant breast and bowel project P-1 breast cancer prevention trial. Cancer Prev Res (Phila) 4:1393–1400
28. Land SR, Liu Q, Wickerham DL et al (2014) Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial. Cancer Epidemiol Biomarkers Prev 23:823–832
29. Lof M, Bergstrom K, Weiderpass E (2012) Physical activity and biomarkers in breast cancer survivors: a systematic review. Maturitas 73:134–142
30. Lyman GH, Sparreboom A (2013) Chemotherapy dosing in overweight and obese patients with cancer. Nat Rev Clin Oncol 10:451–459
31. Mason C, Foster-Schubert KE, Imayama I et al (2011) Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med 41:366–375
32. Mazzarella L, Disalvatore D, Bagnardi V et al (2013) Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients. Eur J Cancer 49:3588–3597
33. Newcomb PA, Kampman E, Trentham-Dietz A et al (2013) Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol 31:1939–1946
34. Niraula S, Ocana A, Ennis M et al (2012) Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat 134:769–781
35. Pajares B, Pollan M, Martin M et al (2013) Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis. Breast Cancer Res 15:R105
36. Pan H, Gray RR, on behalf of the Early Breast Cancer Trialists’ Collaborative Group (2014) Effect of obesity in premenopausal ER+ early breast cancer: EBCTCG data on 80,000 patients in 70 trials. J Clin Oncol 32(Suppl 15):503
37. Pierce JP, Natarajan L, Caan BJ et al (2007) Infl uence of a diet very high in vegetables, fruit, and fi ber and low in fat on prognosis following treatment for breast cancer: the women’s healthy eating and living (WHEL) randomized trial. JAMA 298:289–298
38. Pi-Sunyer X, Blackburn G, Brancati FL et al (2007) Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 30:1374–1383
39. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635
40. Rack B, Andergassen U, Neugebauer J et al (2010) The German SUCCESS C study – the fi rst European lifestyle study on breast cancer. Breast Care (Basel) 5:395–400
41. Reeves MM, Terranova CO, Eakin EG et al (2014) Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev. doi: 10.1111/obr.12190
42. Rock CL, Byers TE, Colditz GA et al (2013) Reducing breast cancer recurrence with weight loss, a vanguard trial: the exercise and nutrition to enhance recovery and good health for you (ENERGY) trial. Contemp Clin Trials 34:282–295
43. Seitz HK, Pelucchi C, Bagnardi V et al (2012) Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol 47:204–212
44. Sestak I, Distler W, Forbes JF et al (2010) Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J Clin Oncol 28:3411–3415
45. Sparano JA, Wang M, Zhao F et al (2012) Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118:5937–5946
46. Suissa S, Pollak M, Spitzer WO et al (1989) Body size and breast cancer prognosis: a statistical explanation of the discrepancies. Cancer Res 49:3113–3116
47. Turkoz FP, Solak M, Petekkaya I et al (2013) The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. J BUON 18:335–341
48. Villarini A, Pasanisi P, Traina A et al (2012) Lifestyle and breast cancer recurrences: the DIANA-5 trial. Tumori 98:1–18